Picture of Enzolytics logo

ENZC Enzolytics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro Cap

Annual cashflow statement for Enzolytics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2008
July 31st
2009
December 31st
C2010
December 31st
2011
December 31st
2012
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10KSB10-KARSARSPRESS
Standards:
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-0.063-0.97-5.37-0.883-0.965
Depreciation
Non-Cash Items0.1420.3535.20.1060.854
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.0780.233-0.390.0870.052
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities0.001-0.371-0.551-0.68-0.05
Capital Expenditures-0.001000
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0
Change in Net Intangibles
Other Investing Cash Flow
Cash from Investing Activities-0.001000
Financing Cash Flow Items0
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities00.3720.5510.6870.041
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash00-00.007-0.008